首页> 外文期刊>Biochemical Pharmacology >First report on the pharmacokinetics of tramadol and O-desmethyltramadol in exhaled breath compared to plasma and oral fluid after a single oral dose
【24h】

First report on the pharmacokinetics of tramadol and O-desmethyltramadol in exhaled breath compared to plasma and oral fluid after a single oral dose

机译:关于单次口服后与血浆和口服液相比呼气中曲马多和O-去甲基曲马多药代动力学的首次报道

获取原文
获取原文并翻译 | 示例
           

摘要

Exhaled breath (EB) is a promising matrix for bioanalysis of non-volatiles and has been routinely implemented for drugs of abuse analysis. Nothing is known regarding the pharmacokinetics of therapeutics and their metabolites in EB. Therefore, we used tramadol as a model drug. Twelve volunteers received a single oral dose of tramadol and repeated sampling of EB, plasma, and oral fluid (OF) was done for 48 h using a particle filter device for EB and the Quantisal-device for OF. Samples were analyzed with LC-MS/MS and the pharmacokinetic correlations between matrices were investigated. The initial tramadol half-life in EB was shorter than in plasma but it reappeared in EB after 8-24 h. The ratio of 0-desmethyltramadol to tramadol was considerably lower in EB and OF compared to plasma. This pilot study compared for the first time the pharmacokinetics of a therapeutic drug and active metabolite in different biomatrices including EB and demonstrated its potential for bioanalysis. (C) 2015 Elsevier Inc. All rights reserved.
机译:呼气(EB)是用于非挥发性物质生物分析的有前途的基质,并且已常规用于滥用药物分析。关于治疗剂及其在EB中的代谢产物的药代动力学还一无所知。因此,我们将曲马多用作模型药物。 12名志愿者接受了曲马多的单次口服剂量,并使用EB粒子过滤器和OF的Quantisal装置对EB,血浆和口服液(OF)进行了48小时的重复采样。用LC-MS / MS分析样品,并研究基质之间的药代动力学相关性。 EB中最初的曲马多半衰期短于血浆中,但在8-24小时后又出现在EB中。与血浆相比,EB和OF中的0-去甲基曲马多与曲马多的比例要低得多。这项初步研究首次比较了治疗药物和活性代谢物在包括EB在内的不同生物基质中的药代动力学,并证明了其生物分析潜力。 (C)2015 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号